High-Throughput In Vitro ADME Analysis with Agilent RapidFire/MS Systems: Cytochrome P450 Inhibition

Importance of the Topic

Understanding cytochrome P450 inhibition is critical in drug discovery to prevent adverse interactions and late-stage failures.
Early identification of metabolic liabilities reduces development costs and enhances safety profiles.

Study Objectives and Overview

This study evaluates the performance of Agilent RapidFire MS systems for high throughput analysis of CYP inhibition assays.
Key goals include:

• Comparing IC50 values from RapidFire MS/MS with traditional LC MS/MS
• Assessing assay throughput and productivity gains
• Demonstrating applicability to direct and time dependent inhibition assays

Applied Methodology and Instrumentation

Assays were performed using pooled human liver microsomes and FDA recommended probe substrates.
Internal standards comprised stable isotope labels for accurate quantification.
The workflow combined Agilent RapidFire sample handling with triple quadrupole mass spectrometry for MS/MS analysis.
Key instrument features:

• RapidFire system with automated solid phase extraction
• Triple quadrupole mass spectrometer for targeted quantitation
• Cycle time of approximately six seconds per sample

Main Results and Discussion

Direct Inhibition Assays

• High correlation (R2 0.986) of IC50 values between RapidFire MS/MS and conventional LC MS/MS
• Throughput improved from 2 to 4 minutes per sample down to roughly six seconds

Time Dependent Inhibition Assays

• Equivalent IC50 shifts for CYP3A4 inhibitors confirmed across both platforms
• Effective analysis of full seven point curves in the time of a single traditional measurement
• Overall productivity increased by more than 20 fold

Benefits and Practical Applications

• Significant reduction in analysis time accelerates ADME screening
• Seamless integration into existing drug discovery workflows
• Cost efficient evaluation of large compound libraries for CYP liability
• Supports early elimination of compounds with undesirable metabolic profiles

Future Trends and Opportunities

• Expansion to additional enzyme classes and metabolite profiling
• Integration with high content data analytics and machine learning
• Miniaturization and multiplexing for ultra high throughput screening
• Coupling with microfluidic platforms for on chip ADME analysis

Conclusion

The Agilent RapidFire MS systems deliver reliable CYP inhibition data with a dramatic increase in throughput compared to traditional LC MS methodologies.
This approach enhances early ADME decision making and optimizes resource allocation in drug discovery projects.

Reference

1. Perloff E et al Validation of cytochrome P450 time dependent inhibition assays a two time point IC50 shift approach facilitates kinact assay design Xenobiotica 2011 39 2 99 112
2. Perloff E et al Comparison of RapidFire Ultra High Throughput LC MS MS with Traditional LC MS MS for Cytochrome P450 Inhibition Testing Abstract 106 11th European ISSX May 2009 Lisbon
3. Miller V et al Evaluation of High Throughput Screening Methods for Time Dependent Inhibition of CYP3A4 Utilizing RapidFire LC MS MS Technology Presented at 11th European ISSX May 2009 Lisbon